臨床薬理学臨床薬理学についてブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは

Squeezing, trisqueezing and quadsqueezing in a hybrid oscillator-spin system.

Nature physics·2026

Breaking the Entangling Gate Speed Limit for Trapped-Ion Qubits Using a Phase-Stable Standing Wave.

Physical review letters·2023

Long-period gratings for monitoring the resin transfer molding of fiber-reinforced polymer composites.

Optics letters·2023

Ultraviolet A radiation and COVID-19 deaths in the USA with replication studies in England and Italy.

The British journal of dermatology·2021

Low-dimensional nano-patterned surface fabricated by direct-write UV-chemically induced geometric inscription technique.

Optics letters·2019

Attending a social event and consuming alcohol is associated with changes in serum microRNA: a before and after study in healthy adults.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2018

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Unveiling the sumatriptan dose-relief relationship.

European journal of clinical pharmacology·2026

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Biological & pharmaceutical bulletin·2026

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Therapeutic drug monitoring·2026

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

International journal of pharmaceutics·2026

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

The Lancet. Neurology·2026

関連する実験動画

臨床薬理学臨床薬理学についてブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology)

関連する概念動画

Squeezing, trisqueezing and quadsqueezing in a hybrid oscillator-spin system.

Breaking the Entangling Gate Speed Limit for Trapped-Ion Qubits Using a Phase-Stable Standing Wave.

Long-period gratings for monitoring the resin transfer molding of fiber-reinforced polymer composites.

Ultraviolet A radiation and COVID-19 deaths in the USA with replication studies in England and Italy.

Low-dimensional nano-patterned surface fabricated by direct-write UV-chemically induced geometric inscription technique.

Attending a social event and consuming alcohol is associated with changes in serum microRNA: a before and after study in healthy adults.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Unveiling the sumatriptan dose-relief relationship.

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

関連する実験動画

臨床薬理学 臨床薬理学について ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology)...

関連する概念動画

関連記事

臨床薬理学臨床薬理学についてブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology) とは,ブルーチップ技術 (Blue-chip technology)